Duane Morris Guides Sex Dysfunction Drug Co.'s Pared IPO
S1 Biopharma Inc., an early-stage biotech company developing drugs treating female sexual dysfunction, downsized its initial public offering Wednesday with the aid of Duane Morris LLP, planning to now issue 1.75...To view the full article, register now.
Already a subscriber? Click here to view full article